NRx Pharmaceuticals Inc. (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, has selected IBN, a multifaceted ...

A single dose of ketamine could alter communication between different brain regions. This discovery opens new perspectives ...

NRx Pharmaceuticals (NASDAQ: NRXP) has filed for the newly launched FDA Commissioner's National Priority Voucher (CNPV) program, seeking accelerated ...

Compass Pathways' psilocybin-based depression therapy reduced the severity of symptoms in a closely watched study, but shares of the biotech firm plunged more than 46% to a record low on Monday as the ...

Inside the dimly lit structure, they uncovered drums of chemicals, sophisticated lab equipment stained with residue and crude ...

Farrah Abraham may not be a regular part of the Teen Mom sphere anymore, but she still has plenty to say about the time she did spend closely associated with the show, and the unceremonious ways in ...

While positive, results from a late-stage clinical trial appear to be raising questions about how useful the company’s ...

The music mogul has pleaded not guilty to charges of sex trafficking, racketeering conspiracy and transportation to engage in ...

It's been nearly two years since the singer's young son was diagnosed with neuroblastoma – an aggressive form of infant ...

Compass Pathways Plc’s shares plummeted after its psychedelic drug to treat a form of depression disappointed investors in a ...

While the longevity industry promotes costly interventions like full-body scans, supplement stacks, and elite wellness ...